Pancreatic Cancer Research

ResearcherQingdao UniversityActive in the last 2 years

Dong Chen

Matched on ORCID iD 0000-0002-9581-8774; OpenAlex author ID A5100698263. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: none · 2015: 3 papers · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. RETRACTED: Chen et al. Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenoc… Co-author DOI 10.3390/ijms27146511↗
  2. Pancreatic stellate cells facilitate pancreatic cancer cell viability and invasion. Co-author DOI 10.3892/ol.2018.9816↗
  3. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression. Last author DOI 10.1186/s12957-015-0451-7↗
  4. Survivin expression and serum levels in pancreatic cancer. Co-author DOI 10.1186/s12957-015-0605-7↗
  5. Environmental tobacco smoke and pancreatic cancer: a case-control study. Last author PMID 26629212↗
  6. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1159/000332423↗
  7. RETRACTED: Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. Co-author DOI 10.3390/ijms13011186↗
  8. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. First author DOI 10.1038/labinvest.2010.201↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kejun Zhang · 4 shared papers, 2011–2026 · strength 0.45
  2. Dianliang Zhang · 1 shared paper, 2026 · strength 0.36
  3. Yanbing Zhou · 1 shared paper, 2019 · strength 0.11
  4. Shanglong Liu · 1 shared paper, 2019 · strength 0.11
  5. Bo Sun · 1 shared paper, 2019 · strength 0.11
  6. Wei Feng · 1 shared paper, 2015 · strength 0.06
  7. Yi Ding · 1 shared paper, 2015 · strength 0.06
  8. He Dong · 1 shared paper, 2015 · strength 0.06
  9. Zimin Liu · 1 shared paper, 2015 · strength 0.06
  10. Min Wang · 1 shared paper, 2015 · strength 0.06
  11. Dianliang Zhang · 1 shared paper, 2012 · strength 0.04
  12. Jingyu Cao · 1 shared paper, 2011 · strength 0.03
  13. Dongsheng Wang · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.